The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

Shares MSCI Denmark ETF (EDEN) is currently trading at an attractive earnings multiple relative to history. See why the ...

Denmark-based pharmaceutical giant Novo Nordisk (NYSE: NVO) has been struggling during the past year. Its financial results - ...

The ballooning obesity drug market may have a new contender after Roche struck a $5.3 billion deal to develop Danish ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Shares in Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy, ...

About a dozen lawsuits, citing 2024 studies, allege Ozempic causes a rare eye disorder that leads to irreversible blindness. ...

COPENHAGEN, Denmark, April 29, 2025 /PRNewswire/ -- The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting ...

Similarly, SKF, a Swedish multinational known for industrial and automotive solutions, operates its Global Technical Centre ...

The global capability centre of Novo Nordisk in India is now closely engaged with the entire value chain of this global ...

Copenhagen, Denmark: The Novo Nordisk Foundation today announced the latest edition of its annual Challenge Programme, where for the first time it is inviting researchers from outside Denmark, in the ...